171 related articles for article (PubMed ID: 34575202)
1. CHA2DS2-VASc Score for Major Adverse Cardiovascular Events Stratification in Patients with Pneumonia with and without Atrial Fibrillation.
Wang BY; Lin FY; Ku MS; Wang YH; Lee KY; Ho SW
J Clin Med; 2021 Sep; 10(18):. PubMed ID: 34575202
[TBL] [Abstract][Full Text] [Related]
2. CHA
Kim TH; Yang PS; Uhm JS; Kim JY; Pak HN; Lee MH; Joung B; Lip GYH
Stroke; 2017 Jun; 48(6):1524-1530. PubMed ID: 28455320
[TBL] [Abstract][Full Text] [Related]
3. Assessment of the CHA2DS2-VASc Score in Predicting Ischemic Stroke, Thromboembolism, and Death in Patients With Heart Failure With and Without Atrial Fibrillation.
Melgaard L; Gorst-Rasmussen A; Lane DA; Rasmussen LH; Larsen TB; Lip GY
JAMA; 2015 Sep; 314(10):1030-8. PubMed ID: 26318604
[TBL] [Abstract][Full Text] [Related]
4. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation.
Roldán V; Marín F; Manzano-Fernández S; Gallego P; Vílchez JA; Valdés M; Vicente V; Lip GY
J Am Coll Cardiol; 2013 Dec; 62(23):2199-204. PubMed ID: 24055744
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of CHA2DS2-VASc score in predicting high SYNTAX score and in-hospital mortality for non-ST elevation myocardial infarction in patients without atrial fibrillation.
Akboğa MK; Yılmaz S; Yalçın R
Anatol J Cardiol; 2021 Nov; 25(11):789-795. PubMed ID: 34734812
[TBL] [Abstract][Full Text] [Related]
6. Usefulness of the 2MACE Score to Predicts Adverse Cardiovascular Events in Patients With Atrial Fibrillation.
Rivera-Caravaca JM; Marín F; Esteve-Pastor MA; Raña-Míguez P; Anguita M; Muñiz J; Cequier Á; Bertomeu-Martínez V; Valdés M; Vicente V; Lip GYH; Roldán V
Am J Cardiol; 2017 Dec; 120(12):2176-2181. PubMed ID: 29111209
[TBL] [Abstract][Full Text] [Related]
7. Study on the predictive ability of emergency CHADS
Huang X; Lv H; Liu Z; Liu Y; Yang X
J Thorac Dis; 2022 Jul; 14(7):2611-2620. PubMed ID: 35928606
[TBL] [Abstract][Full Text] [Related]
8. Assessing the Suitability of CHA
Cheng YT; Chang FL; Li PH; Lu WC; Chiu CS
Biomedicines; 2024 Jun; 12(6):. PubMed ID: 38927581
[TBL] [Abstract][Full Text] [Related]
9. CHA2DS2-VASc score for ischaemic stroke risk stratification in patients with chronic obstructive pulmonary disease with and without atrial fibrillation: a nationwide cohort study.
Hu WS; Lin CL
Europace; 2018 Apr; 20(4):575-581. PubMed ID: 28407109
[TBL] [Abstract][Full Text] [Related]
10. Association of CHA2DS2-VASc score with successful recanalization in acute ischemic stroke patients undergoing endovascular thrombectomy.
Nasifov M; Ozmen E; Deniz C; Nadir A; Ozden O; Bingol G; Jafarov P; Asil T; Goktekin O; Sari I
Postepy Kardiol Interwencyjnej; 2022 Sep; 18(3):269-275. PubMed ID: 36751289
[TBL] [Abstract][Full Text] [Related]
11. CHADS
Wu JT; Wang SL; Chu YJ; Long DY; Dong JZ; Fan XW; Yang HT; Duan HY; Yan LJ; Qian P
J Atheroscler Thromb; 2017 Feb; 24(2):176-184. PubMed ID: 27301462
[TBL] [Abstract][Full Text] [Related]
12. Should atrial fibrillation patients with 1 additional risk factor of the CHA2DS2-VASc score (beyond sex) receive oral anticoagulation?
Chao TF; Liu CJ; Wang KL; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Chen TJ; Lip GY; Chen SA
J Am Coll Cardiol; 2015 Feb; 65(7):635-42. PubMed ID: 25677422
[TBL] [Abstract][Full Text] [Related]
13. The impact of risk score (CHADS2 versus CHA2DS2-VASc) on long-term outcomes after atrial fibrillation ablation.
Jacobs V; May HT; Bair TL; Crandall BG; Cutler M; Day JD; Weiss JP; Osborn JS; Muhlestein JB; Anderson JL; Mallender C; Bunch TJ
Heart Rhythm; 2015 Apr; 12(4):681-6. PubMed ID: 25546809
[TBL] [Abstract][Full Text] [Related]
14. Pre-stroke CHADS2 and CHA2DS2-VASc scores are useful in stratifying three-month outcomes in patients with and without atrial fibrillation.
Tu HT; Campbell BC; Meretoja A; Churilov L; Lees KR; Donnan GA; Davis SM
Cerebrovasc Dis; 2013; 36(4):273-80. PubMed ID: 24135809
[TBL] [Abstract][Full Text] [Related]
15. CHA
Parsons C; Patel SI; Cha S; Shen WK; Desai S; Chamberlain AM; Luis SA; Aguilar MI; Demaerschalk BM; Mookadam F; Shamoun F
Mayo Clin Proc; 2017 Mar; 92(3):360-369. PubMed ID: 28259228
[TBL] [Abstract][Full Text] [Related]
16. CHA2DS2-VASc score is directly associated with the risk of pulmonary embolism in patients with atrial fibrillation.
Saliba W; Rennert G
Am J Med; 2014 Jan; 127(1):45-52. PubMed ID: 24384101
[TBL] [Abstract][Full Text] [Related]
17. Predictive value of CHA2DS2-VASc scores regarding the risk of stroke and all-cause mortality in patients with atrial fibrillation (CONSORT compliant).
Gažová A; Leddy JJ; Rexová M; Hlivák P; Hatala R; Kyselovič J
Medicine (Baltimore); 2019 Aug; 98(31):e16560. PubMed ID: 31374021
[TBL] [Abstract][Full Text] [Related]
18. Mortality Prediction of the CHA
Morrone D; Kroep S; Ricci F; Renda G; Patti G; Kirchhof P; Chuang LH; van Hout B; De Caterina R
J Clin Med; 2020 Dec; 9(12):. PubMed ID: 33317069
[TBL] [Abstract][Full Text] [Related]
19. The CHADS2 and CHA2DS2-VASc scores predict adverse vascular function, ischemic stroke and cardiovascular death in high-risk patients without atrial fibrillation: role of incorporating PR prolongation.
Chan YH; Yiu KH; Lau KK; Yiu YF; Li SW; Lam TH; Lau CP; Siu CW; Tse HF
Atherosclerosis; 2014 Dec; 237(2):504-13. PubMed ID: 25463082
[TBL] [Abstract][Full Text] [Related]
20. R2CHADS2 score and thromboembolic events after catheter ablation of atrial fibrillation in comparison with the CHA2DS2-VASc score.
Chao TF; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Liao JN; Chung FP; Hsieh MH; Chen SA
Can J Cardiol; 2014 Apr; 30(4):405-12. PubMed ID: 24582725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
